ReviewMembranes2022
Interdependence of Kinetics and Fluid Dynamics in the Design of Photocatalytic Membrane Reactors.
Review in Membranes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Removal of Contaminants of Emerging Concern from Wastewater Using Photocatalytic Membranes: Current Status and Challenges.Membranes · 2026Review
- Efficient Removal of PFASs Using Photocatalysis, Membrane Separation and Photocatalytic Membrane Reactors.Membranes · 2024Review
- CFD-Assisted Process Optimization of an Integrated Photocatalytic Membrane System for Water Treatment.Membranes · 2023Article
- Advances in Photocatalytic Membrane Reactor.Membranes · 2023Article
- An Overview of Photocatalytic Membrane Degradation Development.Materials (Basel, Switzerland) · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Photocatalytic membrane reactors (PMRs) are a promising technology for wastewater reclamation. The principles of PMRs are based on photocatalytic degradation and membrane rejection, the different processes occurring simultaneously. Coupled photocatalysis and membrane filtration has made PMRs suitable for application in the removal of emerging contaminants (ECs), such as diclofenac, carbamazepine, ibuprofen, lincomycin, diphenhydramine, rhodamine, and tamoxifen, from wastewater, while reducing the likelihood of byproducts being present in the permeate stream. The viability of PMRs depends on the hypotheses used during design and the kinetic properties of the systems. The choice of design models and the assumptions made in their application can have an impact on reactor design outcomes. A design's resilience is due to the development of a mathematical model that links material and mass balances to various sub-models, including the fluid dynamic model, the radiation emission model, the radiation absorption model, and the kinetic model. Hence, this review addresses the discrepancies with traditional kinetic models, fluid flow dynamics, and radiation emission and absorption, all of which have an impact on upscaling and reactor design. Computational and analytical descriptions of how to develop a PMR system with high throughput, performance, and energy efficiency are provided. The potential solutions are classified according to the catalyst, fluid dynamics, thickness, geometry, and light source used. Two main PMR types are comprehensively described, and a discussion of various influential factors relating to PMRs was used as a premise for developing an ideal reactor. The aim of this work was to resolve potential divergences that occur during PMRs design as most real reactors do not conform to the idealized fluid dynamics. Lastly, the application of PMRs is evaluated, not only in relation to the removal of endocrine-disrupting compounds (EDCs) from wastewater, but also in dye, oil, heavy metals, and pesticide removal.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.